Inventor · disambiguated record
William J. Polvino
Also filed as: POLVINO WILLIAM · POLVINO WILLIAM J
17 granted patents·9 pending applications·86 citations·filing 1997–2024
93Inventor score
Files withHELSINN HEALTHCARE SA5POLVINO WILLIAM J4VELOXIS PHARMACEUTICALS AS4HELSINN THERAPEUTICS US INC2MANN WILLIAM R2
Top patents by PatentIndex Score
26 records- 0193US8039457B2Method of stimulating the motility of the gastrointestinal system using growth hormone secretagoguesHELSINN THERAPEUTICS US INC·Filed 2009·Granted Oct 18, 2011·11 cites·16 claims
- 0292US9775834B2Regimen for supressing organ rejectionVELOXIS PHARMACEUTICALS AS·Filed 2015·Granted Oct 3, 2017·4 cites·9 claims
- 0390US11141408B2Regimen for suppressing organ rejectionVELOXIS PHARMACEUTICALS AS·Filed 2019·Granted Oct 12, 2021·2 cites·24 claims
- 0490US9168246B2Regimen for suppressing organ rejectionVELOXIS PHARMACEUTICALS AS·Filed 2014·Granted Oct 27, 2015·5 cites·11 claims
- 0587US2025099439A1Regimen for suppressing organ rejectionVeloxis Pharmaceuticals·Filed 2024·Application pending·0 cites
- 0686US8039456B2Method of stimulating the motility of the gastrointestinal system using ipamorelinHELSINN THERAPEUTICS US INC·Filed 2008·Granted Oct 18, 2011·11 cites·11 claims
- 0784US8673947B2Enhanced migraine treatments based on ghrelin mimeticsPOLVINO WILLIAM J·Filed 2013·Granted Mar 18, 2014·8 cites·8 claims
- 0883US10278964B2Medical treatments based on anamorelinHELSINN HEALTHCARE SA·Filed 2017·Granted May 7, 2019·4 cites·26 claims
- 0982US10485793B2Regimen for suppressing organ rejectionVELOXIS PHARMACEUTICALS AS·Filed 2017·Granted Nov 26, 2019·2 cites·18 claims
- 1082US8394833B2Methods of treating emesis using growth hormone secretagoguesMANN WILLIAM R·Filed 2012·Granted Mar 12, 2013·7 cites·16 claims
- 1179US2024024303A1Medical Treatments Based on AnamorelinHELSINN HEALTHCARE SA·Filed 2023·Application pending·0 cites
- 1278US8288427B2Methods of treating emesis using growth hormone secretagoguesMANN WILLIAM R·Filed 2008·Granted Oct 16, 2012·4 cites·25 claims
- 1376US11957666B2Regimen for suppressing organ rejectionVELOXIS PHARMACEUTICALS INC·Filed 2021·Granted Apr 16, 2024·0 cites·20 claims
- 1472US11723902B2Medical treatments based on anamorelinHELSINN HEALTHCARE SA·Filed 2020·Granted Aug 15, 2023·0 cites·12 claims
- 1566US5804570AMethod of lessening the risk of non-vertebral bone fracturesMERCK & CO INC·Filed 1997·Granted Sep 8, 1998·28 cites·16 claims
- 1664US10894041B2Medical treatments based on anamorelinHELSINN HEALTHCARE SA·Filed 2019·Granted Jan 19, 2021·0 cites·17 claims
- 1762US2007191283A1Method of stimulating the motility of the gastrointestinal system using growth hormone secretagoguesSAPPHIRE THERAPEUTICS·Filed 2005·Application pending·0 cites
- 1859US2008207640A1Method of treating cell proliferative disorders using growth hormone secretagoguesSAPPHIRE THERAPEUTICS·Filed 2008·Application pending·0 cites
- 1957US2012077745A1Method of stimulating the motility of the gastrointestinal system using growth hormone secretagoguesPOLVINO WILLIAM J·Filed 2011·Application pending·0 cites
- 2055US9675600B2Medical treatments based on anamorelinHELSINN HEALTHCARE SA·Filed 2015·Granted Jun 13, 2017·0 cites·25 claims
- 2151US11964960B2Pyridinone- and pyridazinone-based compounds and uses thereofUNIV CORNELL·Filed 2019·Granted Apr 23, 2024·0 cites·5 claims
- 2251US2012010157A1Method of stimulating the motility of the gastrointestinal system using ipamorelinPOLVINO WILLIAM J·Filed 2011·Application pending·0 cites
- 2351US2006078494A1Use of inhibitors of 24-hydroxylase in the treatment of cancerSAPPHIRE THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2447US8486976B2Enhanced migraine treatments based on ghrelin mimeticsPOLVINO WILLIAM J·Filed 2010·Granted Jul 16, 2013·0 cites·5 claims
- 2541US2006074109A1Use of inhibitors of 24-hydroxylase in the treatment of cancerSAPPHIRE THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2641US2005261201A1Method of reducing C-reactive protein using growth hormone secretagoguesREJUVENON CORP·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →